#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	512	306	ANT_2____Ia	750	145	97.3	ANT_2____Ia.l15.c4.ctg.2	160	29.7	0	.	p	.	0	F31_V32insG	INS	91	91	T	29	29	T	19	T	19	.	Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii;ANT(2'')-Ia
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	512	306	ANT_2____Ia	750	77	100.0	ANT_2____Ia.l15.c4.ctg.3	104	33.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii;ANT(2'')-Ia
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1004	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1098	49.2	0	.	p	.	0	K29T	NONSYN	85	87	AAG	338	340	ACG	71;72;68	A;C;G	71;72;67	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	T879G	SNP	879	879	T	39	39	G	2	G	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	G880A	SNP	880	880	G	40	40	A	2	A	2	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	A888G	SNP	888	888	A	48	48	G	5	G	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	C897G	SNP	897	897	C	57	57	G	19	G	19	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	T898C	SNP	898	898	T	58	58	C	24	C	23	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	G906T	SNP	906	906	G	66	66	T	44	T	44	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	G908A	SNP	908	908	G	68	68	A	46	A	46	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	A918T	SNP	918	918	A	78	78	T	53	T	53	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	A943G	SNP	943	943	A	103	103	G	106	G	105	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	560	518	Chlamydophila_psittaci_16S	1507	138	91.3	Chlamydophila_psittaci_16S.l15.c4.ctg.1	209	32.9	0	.	n	.	0	G991T	SNP	991	991	G	151	151	T	59	T	58	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3808	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1409	134.4	1	SNP	p	R234F	1	.	.	700	702	TTC	899	901	TTC	194;191;192	T;T;C	193;190;191	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3808	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1409	134.4	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1199	1201	CGT	156;163;165	C;G;T	156;163;163	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3808	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1409	134.4	0	HET	.	.	.	T180C	.	180	180	T	379	379	T	102	T,C	55,38	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3808	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1409	134.4	0	HET	.	.	.	C261T,G	.	261	261	C	460	460	C	151	C,T,G	81,67,1	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3808	Escherichia_coli_EF_Tu	1230	1210	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1409	134.4	0	HET	.	.	.	C144T	.	144	144	C	343	343	C	91	C,T	52,39	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	3808	Escherichia_coli_EF_Tu	1230	71	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	257	16.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1176	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1765	35.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1569	1571	AAA	14;14;14	A;A;A	14;14;14	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1724	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1787	51.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1248	1250	GAA	68;69;70	G;A;A	68;69;70	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	536	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	825	34.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1041G	SNP	1041	1041	T	15	15	G	200	G	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1042T	SNP	1042	1042	A	16	16	T	206	T	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1136G	SNP	1136	1136	A	110	110	G	306	G	305	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1138C	SNP	1138	1138	T	112	112	C	300	C	298	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1142C	SNP	1142	1142	T	116	116	C	286	C	286	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	C1170T	SNP	1170	1170	C	144	144	T	247	T	245	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1220C	SNP	1220	1220	T	194	194	C	228	C	227	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1245C	SNP	1245	1245	T	219	219	C	202	C,T	201,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	G1253A	SNP	1253	1253	G	227	227	A	218	A	217	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	G1256A	SNP	1256	1256	G	230	230	A	219	A	219	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	C1258A	SNP	1258	1258	C	232	232	A	216	A	216	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	G1266T	SNP	1266	1266	G	240	240	T	208	T	206	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1267C	SNP	1267	1267	T	241	241	C	207	C	207	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1275C	SNP	1275	1275	T	249	249	C	177	C	177	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	G1276A	SNP	1276	1276	G	250	250	A	176	A	175	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1281G	SNP	1281	1281	A	255	255	G	162	G	162	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1283C	SNP	1283	1283	T	257	257	C	161	C	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	G1288T	SNP	1288	1288	G	262	262	T	165	T	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1296G	SNP	1296	1296	A	270	270	G	222	G	221	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1299G	SNP	1299	1299	T	273	273	G	241	G	240	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1300T	SNP	1300	1300	A	274	274	T	244	T	243	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	C1356T	SNP	1356	1356	C	330	330	T	276	T	276	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1358G	SNP	1358	1358	A	332	332	G	257	G	257	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1368C	SNP	1368	1368	T	342	342	C	199	C	199	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	G1370A	SNP	1370	1370	G	344	344	A	185	A	185	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	C1406.	DEL	1406	1406	C	379	379	C	71	C	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	.1409C	INS	1409	1409	T	383	383	C	64	C	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	C1431A	SNP	1431	1431	C	405	405	A	4	A	4	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	C1432A	SNP	1432	1432	C	406	406	A	3	A	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1441G	SNP	1441	1441	A	415	415	G	3	G	3	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	T1464C	SNP	1464	1464	T	438	438	C	33	C	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	G1473T	SNP	1473	1473	G	447	447	T	117	T,G	116,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1475G	SNP	1475	1475	A	449	449	G	134	G	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	.	n	.	0	A1548T	SNP	1548	1548	A	522	522	T	119	T	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	1	SNP	n	C1194G	0	.	.	1194	1194	C	168	168	C	214	C	213	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	525	91.63	Pasteurella_multocida_16S.l15.c30.ctg.2	560	220.2	0	HET	.	.	.	C1040T	.	1040	1040	T	14	14	C	181	C,T	87,46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	87	97.7	Pasteurella_multocida_16S.l15.c30.ctg.3	93	194.8	0	.	n	.	0	A303G	SNP	303	303	A	8	8	G	86	G	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	4682	Pasteurella_multocida_16S	1551	87	97.7	Pasteurella_multocida_16S.l15.c30.ctg.3	93	194.8	0	.	n	.	0	G375A	SNP	375	375	G	80	80	A	111	A	109	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1354	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1473	49.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	203	205	CGT	57;57;56	C;G;T	57;57;56	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1354	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1473	49.4	0	.	p	.	0	V30I	NONSYN	88	90	GTC	287	289	ATC	52;49;46	A;T;C	51;49;46	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1354	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1473	49.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1046	1048	GGC	58;58;56	G;G;C	58;57;56	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2010	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2004	53.9	0	.	p	.	0	R8S	NONSYN	22	24	AGA	207	209	AGC	31;30;32	A;G;C	31;30;32	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2010	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2004	53.9	0	.	p	.	0	I142L	NONSYN	424	426	ATA	609	611	CTA	51;51;52	C;T,A;A	50;50,1;52	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2010	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2004	53.9	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1128	1130	CAA	82;86;87	C;A;A	82;86;87	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2010	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2004	53.9	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1227	1229	GGT	63;67;69	G;G;T	63;66;68	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	2010	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2004	53.9	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1797	1799	GTT	30;27;25	G;T;T	30;27;25	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1158	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1552	40.2	0	.	p	.	0	A125E	NONSYN	373	375	GCA	570	572	GAA	35;35;36	G;A;A	35;35;36	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1158	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1552	40.2	0	.	p	.	0	M185T	NONSYN	553	555	ATG	750	752	ACC	15;15;15	A;C;C	15;15;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1158	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1552	40.2	0	.	p	.	0	S225T	NONSYN	673	675	TCC	870	872	ACT	22;24;22	A;C;T	22;24;22	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1158	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1552	40.2	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1260	1262	ATC	33;34;34	A;T;C	33;33;34	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	1	1188	PmrF	969	642	99.07	PmrF.l15.c30.ctg.1	893	41.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	1	1188	PmrF	969	330	100.0	PmrF.l15.c30.ctg.2	710	34.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aadA.3002601.NC_010410.3621491_3622283.725	aadA.3002601.NC_010410.3621491_3622283.725	1	0	539	1208	aad-	792	792	99.75	aad-.l15.c4.ctg.2	1264	38.8	0	.	p	.	0	A4V	NONSYN	10	12	GCG	228	230	GTG	39;40;41	G;T;G	38;40;41	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	16	82	acrB	3147	141	91.49	acrB.l15.c30.ctg.1	144	11.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	acrB;Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3276	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3380	51.8	0	.	p	.	0	T85I	NONSYN	253	255	ACC	428	430	ATC	57;57;55	A;T;C	57;56;55	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3276	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3380	51.8	0	.	p	.	0	A177T	NONSYN	529	531	GCC	704	706	ACC	66;71;76	A;C;C	66;71;76	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3276	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3380	51.8	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2141	2143	AAG	39;41;40	A;A;G	39;41;40	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1444	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1562	49.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	272	274	GTC	14;14;14	G;T;C	14;14;14	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1444	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1562	49.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1013	1015	TGC	69;66;68	T;G;C	69;65;68	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3454	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	2863	63.6	0	.	p	.	0	S46trunc	TRUNC	136	136	T	207	207	T	36	T	35	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3454	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	2863	63.6	0	.	p	.	0	G148D	NONSYN	442	444	GGC	513	515	GAC	76;75;74	G;A;C,G	74;73;72,1	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3454	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	2863	63.6	0	.	p	.	0	F240L	NONSYN	718	720	TTT	789	791	TTA	35;35;35	T;T;A	35;35;35	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3454	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	2863	63.6	0	.	p	.	0	D301N	NONSYN	901	903	GAT	972	974	AAT	48;48;48	A;A;T	48;48;48	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3454	acrF	3105	2598	98.5	acrF.l15.c30.ctg.1	2863	63.6	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1759	1759	T	89	T	89	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	882	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1064	44.6	1	SNP	p	R45C	0	.	.	133	135	CGC	332	334	CGC	55;54;52	C;G;C	55;53;52	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	876	acrS	663	663	98.64	acrS.l15.c30.ctg.1	905	51.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	173	175	TTC	38;38;40	T;T;C	38;38;40	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	876	acrS	663	663	98.64	acrS.l15.c30.ctg.1	905	51.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	437	439	GGG	63;64;66	G;G;G	63;64;65	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1136	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1173	52.0	0	.	p	.	0	V136L	NONSYN	406	408	GTT	619	621	CTT	83;81;82	C;T;T	83;81;82	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3420	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3039	60.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2053	2055	GCA	81;82;84	G;C;A	80;82;84	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3420	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3039	60.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2314	2316	ACC	77;77;78	A;C;C	76;77;78	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3420	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3039	60.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2623	2625	GCC	52;48;49	G;C;C	52;48;49	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1656	arnA_1	1983	1983	98.24	arnA_1.l6.c17.ctg.1	2289	38.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	231	233	GCT	7;7;8	G;C;T	7;7;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1656	arnA_1	1983	1983	98.24	arnA_1.l6.c17.ctg.1	2289	38.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	351	353	GAG	9;8;7	G;A;G	9;8;7	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1656	arnA_1	1983	1983	98.24	arnA_1.l6.c17.ctg.1	2289	38.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	387	389	TGC	9;10;12	T;G;C	9;10;12	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1656	arnA_1	1983	1983	98.24	arnA_1.l6.c17.ctg.1	2289	38.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	570	572	GTT	29;30;31	G;T;T	29;30;31	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1656	arnA_1	1983	1983	98.24	arnA_1.l6.c17.ctg.1	2289	38.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	720	722	CAC	39;39;40	C;A;C	39;39;40	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1656	arnA_1	1983	1983	98.24	arnA_1.l6.c17.ctg.1	2289	38.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1005	1007	ATG	58;61;64	A;T;G,T	55;59;60,1	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1656	arnA_1	1983	1983	98.24	arnA_1.l6.c17.ctg.1	2289	38.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2001	2003	CGC	35;32;33	C;G;C	35;32;33	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	742	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1210	33.0	0	.	p	.	0	S221T	NONSYN	661	663	AGC	880	882	ACC	16;15;15	A;C;C	15;15;15	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	742	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1210	33.0	0	.	p	.	0	P225S	NONSYN	673	675	CCG	892	894	TCG	18;19;20	T;C;G	18;19;20	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	668	baeR	723	723	97.79	baeR.l6.c17.ctg.1	1069	33.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1138	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1753	34.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1280	1282	AAA	22;22;22	A;A;A	19;22;22	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1138	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1753	34.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1292	1294	GAG	19;19;19	G;A;G	18;17;19	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1138	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1753	34.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1298	1300	CAC	15;16;15	C;A;C	14;16;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1138	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1753	34.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1352	1354	GAG	24;23;24	G;A;G	24;23;24	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
blaOXA_1.manually_added_JN003856.1_AEM36717.1_214_1044	blaOXA_1.manually_added_JN003856.1_AEM36717.1_214_1044	1	0	27	858	OXA_1+	831	831	100.0	OXA_1+.l15.c4.ctg.1	1298	35.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: JN003856.1 Salmonella enterica subsp. enterica serovar Typhimurium strain 18-425 class I integron beta-lactamase OXA-1 (blaOXA-1) and aminoglycoside adenyltransferase A (aadA1) genes, complete cds
catI.3002683.V00622.243_903.482	catI.3002683.V00622.243_903.482	1	0	27	852	cat+	660	660	99.85	cat+.l15.c4.ctg.1	1090	42.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	catI;catI is a chromosome and transposon-encoded variant of the cat gene found in Escherichia coli and Acinetobacter baumannii
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1472	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1839	43.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1050	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1081	52.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	1464	cysB	975	975	99.28	cysB.l15.c30.ctg.1	1346	58.6	0	.	p	.	0	A146T	NONSYN	436	438	GCT	625	627	ACT	56;58;57	A;C;T	56;57;57	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1330	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1562	45.7	0	.	p	.	0	I219V	NONSYN	655	657	ATC	844	846	GTC	69;67;64	G;T;C	68;67;63	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1760	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	1939	48.8	0	.	p	.	0	E197K	NONSYN	589	591	GAA	795	797	AAA	60;60;58	A;A;A	60;60;58	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	1222	emrD	1191	1089	98.35	emrD.l15.c17.ctg.1	1290	47.4	0	.	p	.	0	G209S	NONSYN	625	627	GGC	826	828	AGC	33;34;31	A;G;C	33;34;31	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	515	1222	emrD	1191	99	98.99	emrD.l15.c17.ctg.2	254	17.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	60	emrE_1	333	95	96.84	emrE_1.l15.c4.ctg.4	117	12.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1284	emrK	1056	1056	98.11	emrK.l6.c30.ctg.1	1468	47.0	0	.	p	.	0	V111G	NONSYN	331	333	GTT	535	537	GGT	26;26;26	G;G;T	26;26;26	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1284	emrK	1056	1056	98.11	emrK.l6.c30.ctg.1	1468	47.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	730	732	AGG	25;26;28	A;G;G	25;26;28	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1284	emrK	1056	1056	98.11	emrK.l6.c30.ctg.1	1468	47.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1120	1122	GAC	32;31;31	G;A;C	32;31;31	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	876	emrR	531	531	100.0	emrR.l15.c4.ctg.1	952	49.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1962	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1928	54.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	770	evgA	615	615	99.19	evgA.l15.c30.ctg.1	887	44.5	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	269	271	CTG	67;65;63	C;T;G	65;65;63	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	T38I	NONSYN	112	114	ACA	318	320	ATA	31;30;27	A;T;A	31;30;26	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	L42V	NONSYN	124	126	CTA	330	332	GTA	16;17;17	G;T;A	16;17;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	A93T	NONSYN	277	279	GCG	483	485	ACG	34;37;37	A;C;G	34;37;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	A114E	NONSYN	340	342	GCA	546	548	GAA	49;49;50	G;A;A	49;49;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	T127A	NONSYN	379	381	ACT	585	587	GCT	59;60;60	G;C;T	58;60;60	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	N133D	NONSYN	397	399	AAT	603	605	GAT	49;47;47	G;A;T	49;47;47	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	P162S	NONSYN	484	486	CCA	690	692	TCA	31;32;32	T;C;A	31;32;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	819	821	CAG	36;34;33	C;A;G	36;34;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	I251V	NONSYN	751	753	ATT	957	959	GTT	50;50;50	G;T;T	50;50;50	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1113	1115	GAT	8;8;8	G;A;T	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1281	1283	AAT	16;16;15	A;A;T	16;16;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1302	1304	TTA	4;4;3	T;T;A	4;4;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1503	1505	AAA	36;35;35	A;A;A	36;35;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2238	2240	CAT	56;57;55	C;A;T	56;57;55	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2292	2294	CAT	49;49;49	C;A;T	49;49;49	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2310	2312	AGA	46;45;46	A;G;A	46;45;46	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2325	2327	AAT	38;36;35	A;A;T	38;36;35	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2472	2474	TCC	25;25;24	T;C;C	25;25;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2637	2639	ATT	42;40;39	A;T;T	42;40;39	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2658	2660	GAT	43;42;43	G;A;T	43;42;43	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2772	2774	GTT	71;70;67	G;T;T	71;69;67	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	3624	evgS	3594	3594	97.52	evgS.l15.c17.ctg.1	3994	48.9	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3057	3059	CAC	57;57;59	C;A;C	57;57;58	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1028	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1216	45.6	1	SNP	p	P64R	0	.	.	190	192	CCA	350	352	CCA	75;74;74	C;C;A	75;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1028	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1216	45.6	1	SNP	p	P64S	0	.	.	190	192	CCA	350	352	CCA	75;74;74	C;C;A	75;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1028	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1216	45.6	1	SNP	p	P64H	0	.	.	190	192	CCA	350	352	CCA	75;74;74	C;C;A	75;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1028	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1216	45.6	1	SNP	p	P64L	0	.	.	190	192	CCA	350	352	CCA	75;74;74	C;C;A	75;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1028	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1216	45.6	1	SNP	p	P64A	0	.	.	190	192	CCA	350	352	CCA	75;74;74	C;C;A	75;74;71	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	844	gadE	528	528	100.0	gadE.l15.c17.ctg.1	952	47.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	250	gadW	729	147	97.28	gadW.l15.c30.ctg.1	147	37.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	250	gadW	729	141	95.74	gadW.l15.c30.ctg.2	141	22.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	10	12	AAT	4;5;5	A;A;T	4;5;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	908	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1216	40.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	321	323	TTA	53;51;51	T;T;A	53;51;51	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	908	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1216	40.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	399	401	ATT	39;39;37	A;T;T	39;38;37	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	908	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1216	40.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	900	902	GGA	48;48;49	G;G;A	48;48;49	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	908	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1216	40.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	906	908	CCG	39;40;40	C;C;G	39;40;40	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2240	2242	GAA	52;51;51	G;A;A	52;50;50	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	S83I	0	.	.	247	249	TCG	455	457	TCG	50;49;52	T;C;G,T	48;47;50,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	S83L	0	.	.	247	249	TCG	455	457	TCG	50;49;52	T;C;G,T	48;47;50,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	S83W	0	.	.	247	249	TCG	455	457	TCG	50;49;52	T;C;G,T	48;47;50,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	D87N	0	.	.	259	261	GAC	467	469	GAC	45;44;46	G;A;C	44;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	D87V	0	.	.	259	261	GAC	467	469	GAC	45;44;46	G;A;C	44;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	467	469	GAC	45;44;46	G;A;C	44;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	D87H	0	.	.	259	261	GAC	467	469	GAC	45;44;46	G;A;C	44;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	3060	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3034	54.3	1	SNP	p	D87G	0	.	.	259	261	GAC	467	469	GAC	45;44;46	G;A;C	44;42;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2598	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2843	49.2	1	SNP	p	R136L	0	.	.	406	408	CGC	610	612	CGC	51;50;52	C;G;C	51;50;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2598	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2843	49.2	1	SNP	p	R136G	0	.	.	406	408	CGC	610	612	CGC	51;50;52	C;G;C	51;50;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2598	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2843	49.2	1	SNP	p	R136E	0	.	.	406	408	CGC	610	612	CGC	51;50;52	C;G;C	51;50;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2598	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2843	49.2	1	SNP	p	R136I	0	.	.	406	408	CGC	610	612	CGC	51;50;52	C;G;C	51;50;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2598	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2843	49.2	1	SNP	p	R136H	0	.	.	406	408	CGC	610	612	CGC	51;50;52	C;G;C	51;50;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2598	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2843	49.2	1	SNP	p	R136S	0	.	.	406	408	CGC	610	612	CGC	51;50;52	C;G;C	51;50;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2598	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2843	49.2	1	SNP	p	R136C	0	.	.	406	408	CGC	610	612	CGC	51;50;52	C;G;C	51;50;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	552	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1039	28.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	425	427	CCG	36;36;35	C;C;G	36;36;35	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	552	kdpE	678	678	98.23	kdpE.l15.c17.ctg.1	1039	28.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	578	580	GCC	27;27;27	G;C;C	26;27;27	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1322	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1324	53.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	207	209	TCA	44;45;48	T;C;A	44;45;48	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	574	marA	384	384	99.74	marA.l15.c17.ctg.1	874	35.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	455	457	AGC	22;21;19	A;G;C	21;21;19	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	557	559	CAT	10;9;8	C;A;T	10;9;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	V45E	0	.	.	133	135	GTG	281	283	GTG	36;35;33	G;T;G	36;35;33	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	I49S	0	.	.	145	147	ATC	293	295	ATC	34;34;32	A;T;C	34;34;32	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	A70T	0	.	.	208	210	GCA	356	358	GCA	30;30;30	G;C;A	30;30;30	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	R73C	0	.	.	217	219	CGT	365	367	CGT	29;29;28	C;G;T	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	R73S	0	.	.	217	219	CGT	365	367	CGT	29;29;28	C;G;T	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	R77C	0	.	.	229	231	CGC	377	379	CGC	28;27;26	C;G;C	28;27;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	R77L	0	.	.	229	231	CGC	377	379	CGC	28;27;26	C;G;C	28;27;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	L78M	0	.	.	232	234	CTG	380	382	CTG	26;25;23	C;T;G,A	26;25;22,1	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	R94H	0	.	.	280	282	CGC	428	430	CGC	21;21;21	C;G;C	20;20;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	R94S	0	.	.	280	282	CGC	428	430	CGC	21;21;21	C;G;C	20;20;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	304	marR	435	435	97.7	marR.l6.c30.ctg.1	718	21.7	1	SNP	p	V96E	0	.	.	286	288	GTA	434	436	GTA	21;22;23	G;T;A	21;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	S7F	NONSYN	19	21	TCC	212	214	TTC	11;10;10	T;T;C	11;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	R36I	NONSYN	106	108	AGG	299	301	ATC	17;17;16	A;T;C	17;17;16	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	E42A	NONSYN	124	126	GAA	317	319	GCC	6;6;6	G;C;C	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	N43V	NONSYN	127	129	AAT	320	322	GTG	5;6;6	G;T;G	5;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	E52D	NONSYN	154	156	GAG	347	349	GAT	9;9;9	G;A;T	9;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	N59T	NONSYN	175	177	AAC	368	370	ACC	10;10;10	A;C;C	10;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	I68L	NONSYN	202	204	ATA	395	397	TTA	12;10;12	T;T;A	12;10;12	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	536	538	CAG	41;42;42	C;A;G	41;42;42	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	D128A	NONSYN	382	384	GAC	575	577	GCC	30;32;34	G;C;C	30;32;34	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	S163A	NONSYN	487	489	TCG	680	682	GCG	31;30;30	G;C;G	30;29;30	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	L231V	NONSYN	691	693	CTT	884	886	GTT	23;23;23	G;T;T	17;19;18	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	854	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1613	28.5	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1046	1046	C	22	C	22	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	918	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1627	30.3	0	.	p	.	0	V12trunc	TRUNC	34	34	G	212	212	G	48	G	47	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	918	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1627	30.3	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	269	271	CAG	20;21;21	C;A;G	20;20;21	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	918	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1627	30.3	0	.	p	.	0	T83I	NONSYN	247	249	ACC	419	421	ATC	22;21;20	A;T;C	22;20;20	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	918	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1627	30.3	0	.	p	.	0	I99M	NONSYN	295	297	ATA	467	469	ATG	7;7;9	A;T;G	7;7;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	918	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1627	30.3	0	.	p	.	0	A130T	NONSYN	388	390	GCC	560	562	ACC	19;18;17	A;C;C	18;18;17	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	918	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1627	30.3	0	.	p	.	0	P257T	NONSYN	769	771	CCG	941	943	ACG	38;39;39	A;C;G,A	38;39;38,1	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3208	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3446	50.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1949	1951	ACC	75;74;77	A;C;C	74;74;77	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3208	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3446	50.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2342	2344	CAA	40;39;40	C;A;A	37;39;37	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3208	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3446	50.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2510	2512	ATT	29;29;29	A;T;T	29;29;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3208	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3446	50.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2594	2596	GTT	46;47;51	G;T;T	46;47;50	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3208	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3446	50.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2702	2704	GAG	28;30;29	G;A;G	28;30;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3208	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3446	50.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2930	2932	ATG	33;29;29	A;T;G	33;29;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3208	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3446	50.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3065	3067	GAT	46;45;44	G;A;T	46;42;43	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2850	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3278	46.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	316	318	ATG	24;24;25	A;T;G	24;24;25	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2850	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3278	46.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	802	804	ATC	56;56;58	A;T;C	55;56;58	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2850	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3278	46.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3118	3120	CAC	10;10;9	C;A;C	10;10;9	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2850	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3278	46.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3121	3123	CTC	8;8;9	C;T;C	8;8;9	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1366	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1800	40.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	183	185	GAA	28;28;29	G;A;A	28;28;29	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1366	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1800	40.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	852	854	GCG	50;52;51	G;C;G	50;51;51	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1366	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1800	40.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1194	1196	ATC	40;38;40	A;T;C	39;37;38	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1366	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1800	40.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1497	1499	TTT	55;57;60	T;T;T	55;57;60	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1658	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1552	57.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4000	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3569	60.4	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1083	1085	ACC	55;54;54	A;C;C	53;47;54	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	4000	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3569	60.4	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2325	2327	GAC	77;79;80	G;A;C	76;79;80	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1264	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1472	39.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	615	617	ATC	35;35;35	A;T;C	35;35;35	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1264	mdtG	1227	163	99.39	mdtG.l15.c30.ctg.2	321	21.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	171	173	GGA	15;17;16	G;G;A	15;17;16	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1032	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.2	1354	38.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	400	402	TGT	41;44;44	T;G;T	41;44;44	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1032	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.2	1354	38.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	970	972	TTG	43;43;42	T;T;G	43;43;42	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1032	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.2	1354	38.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1180	1182	ACG	20;22;20	A;C;G	20;22;20	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1330	mdtL	1176	1176	98.38	mdtL.l15.c17.ctg.1	1632	43.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	777	779	TCC	35;39;42	T;C;C	33;39;42	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	926	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1283	37.0	0	.	p	.	0	V119I	NONSYN	355	357	GTT	554	556	ATT	33;34;33	A;T;T	33;34;33	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	V11M	NONSYN	31	33	GTG	120	122	ATG	25;25;25	A;T;G	25;25;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	T33I	NONSYN	97	99	ACC	186	188	ATC	25;25;26	A;T;C	25;25;26	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	C116R	NONSYN	346	348	TGC	435	437	CGC	56;54;54	C;G;C	56;54;54	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	N238S	NONSYN	712	714	AAC	801	803	AGC	38;38;39	A;G;C	38;38;38	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1002	1004	GTG	45;44;47	G;T;G	45;42;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1065	1067	AAC	15;17;17	A;A;C	15;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1110	1112	GTC	38;39;40	G;T;C	37;39;40	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1140	1142	ATA	68;67;68	A;T;A	68;67;67	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1248	1250	TCT	35;34;36	T;C;T	35;34;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1635	1637	GCG	60;61;61	G;C;G	60;60;60	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2102	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2428	46.4	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1848	1850	ATC	53;53;50	A;T;C	52;53;50	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	S129A	NONSYN	385	387	TCA	473	475	GCG	41;40;44	G;C;G	40;39;44	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	A187T	NONSYN	559	561	GCC	647	649	ACC	36;36;34	A;C;C	35;36;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	H211R	NONSYN	631	633	CAC	719	721	CGC	43;44;47	C;G;C	43;44;46	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	V250A	NONSYN	748	750	GTT	836	838	GCT	44;40;40	G;C;T	44;40;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	R278K	NONSYN	832	834	AGA	920	922	AAA	27;27;27	A;A;A	27;27;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	938	940	CGA	28;28;29	C;G;A	28;28;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1103	1105	GCC	26;27;27	G;C;C	26;27;27	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1115	1117	GAT	32;32;32	G;A;T	32;32;32	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1242	mdtP	1467	1464	97.95	mdtP.l15.c30.ctg.1	1552	41.2	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1532	1534	GCT	13;12;12	G;C;T	13;12;12	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3240	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3822	45.6	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1487	1489	AAG	43;43;43	A;A;G	43;43;43	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3240	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3822	45.6	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2564	2566	CTG	35;37;37	C;T;G	35;37;37	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	266	mgrB	144	144	100.0	mgrB.l15.c17.ctg.1	168	42.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2400	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2111	61.2	0	.	p	.	0	S278N	NONSYN	832	834	AGC	994	996	AAC	47;46;47	A;A;C	47;46;47	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	2400	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2111	61.2	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1540	1542	ATA	76;77;80	A;T;A	76;77;79	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1718	murA_12	1260	1260	98.49	murA_12.l15.c17.ctg.1	1656	55.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1300	1302	GAT	62;65;66	G;A;T	62;65;65	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1718	murA_12	1260	1260	98.49	murA_12.l15.c17.ctg.1	1656	55.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1303	1305	CTG	67;66;62	C;T;G	67;66;62	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1858	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1495	66.8	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1150	1152	GAG	81;76;76	G;A;G	81;76;76	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1858	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1495	66.8	1	SNP	p	G141E	0	.	.	421	423	GGT	637	639	GGT	76;74;71	G;G;T	76;74;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1858	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1495	66.8	1	SNP	p	G141D	0	.	.	421	423	GGT	637	639	GGT	76;74;71	G;G;T	76;74;71	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1858	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1495	66.8	1	SNP	p	R154A	0	.	.	460	462	CGT	676	678	CGT	87;89;89	C;G;T	87;89;88	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1858	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1495	66.8	1	SNP	p	R154D	0	.	.	460	462	CGT	676	678	CGT	87;89;89	C;G;T	87;89;88	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2762	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2688	55.3	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1804	1806	GTG	75;77;77	G;T;G	75;75;77	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2762	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2688	55.3	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1831	1833	TCG	74;71;69	T;C;G	61;63;63	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2762	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2688	55.3	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2446	2448	AAC	39;38;37	A;A;C	39;37;37	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2762	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2688	55.3	1	SNP	p	A85T	0	.	.	253	255	GCG	460	462	GCG	59;60;59	G;C;G	55;57;58	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2762	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2688	55.3	1	SNP	p	D111H	0	.	.	331	333	GAT	538	540	GAT	49;50;51	G;A;T	49;49;51	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2762	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2688	55.3	1	SNP	p	S129P	0	.	.	385	387	TCC	592	594	TCC	55;54;53	T;C;C	53;54;53	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1842	parE_1	1893	1893	97.52	parE_1.l6.c17.ctg.1	2240	43.3	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1498	1500	AAC	59;60;62	A;A;C	59;60;62	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1842	parE_1	1893	1893	97.52	parE_1.l6.c17.ctg.1	2240	43.3	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1507	1509	GAT	59;58;61	G;A;T	59;58;61	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1644	patA	1380	1380	99.78	patA.l15.c17.ctg.1	1821	48.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	825	827	CAG	47;46;46	C;A;G	47;46;46	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1644	patA	1380	1380	99.78	patA.l15.c17.ctg.1	1821	48.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1299	1301	GAT	53;49;47	G;A;T	53;49;47	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	V146F	0	.	.	436	438	GTT	618	620	GTT	67;66;65	G;T;T	67;66;65	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1719	1721	CAG	68;69;73	C;A;G	67;68;72	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1719	1721	CAG	68;69;73	C;A;G	67;68;72	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1758	1760	CAC	54;52;51	C;A;C,A	53;51;48,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1767	1769	CGT	51;52;52	C;G;T	51;51;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1767	1769	CGT	51;52;52	C;G;T	51;51;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1773	1775	TCC	50;48;42	T;C;C	50;48;42	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1779	1781	CTC	41;41;41	C;T;C	41;41;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1869	1871	ACC	83;87;89	A;C;C	83;87;89	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1872	1874	CCT	85;84;81	C;C;T	84;84;81	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5762	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4412	70.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2241	2243	CGT	124;119;117	C;G;T	124;119;117	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	549	455.9	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	407	A	407	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	549	455.9	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	407	A	407	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	549	455.9	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	407	A	407	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	.	n	.	0	A226G	SNP	226	226	A	253	253	G	494	G	491	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	1	SNP	n	A794G	0	.	.	794	794	A	821	821	A	369	A	366	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	1	SNP	n	A794T	0	.	.	794	794	A	821	821	A	369	A	366	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	1	SNP	n	G926T	0	.	.	926	926	G	953	953	G	368	G	367	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	1	SNP	n	G926A	0	.	.	926	926	G	953	953	G	368	G	367	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	1	SNP	n	G926C	0	.	.	926	926	G	953	953	G	368	G	367	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	A79G,C	.	79	79	A	106	106	A	431	A,G,C	338,90,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	C719T	.	719	719	C	746	746	C	336	C,T	208,126	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	T273A	.	273	273	T	300	300	T	419	T,A	317,100	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	C183T	.	183	183	C	210	210	C	440	C,T	302,134	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	A250T	.	250	250	A	277	277	A	474	A,T	375,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	G474A	.	474	474	G	501	501	G	486	G,A	378,103	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	A253T	.	253	253	A	280	280	A	472	A,T	375,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1028	407.9	0	HET	.	.	.	C194T	.	194	194	C	221	221	C	436	C,T	348,85	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	143	100.0	rrsB+.l15.c17.ctg.3	143	97.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	139	95.0	rrsB+.l15.c17.ctg.5	139	64.3	0	.	n	.	0	G1002A	SNP	1002	1002	G	51	51	A	114	A	114	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	139	95.0	rrsB+.l15.c17.ctg.5	139	64.3	0	.	n	.	0	G1006C	SNP	1006	1006	G	55	55	C	128	C	128	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	139	95.0	rrsB+.l15.c17.ctg.5	139	64.3	0	.	n	.	0	T1010C	SNP	1010	1010	T	59	59	C	134	C	133	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	139	95.0	rrsB+.l15.c17.ctg.5	139	64.3	0	.	n	.	0	A1019.	DEL	1019	1019	A	67	67	G	134	G	134	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	139	95.0	rrsB+.l15.c17.ctg.5	139	64.3	0	.	n	.	0	.1023G	INS	1023	1023	T	72	72	G	129	G,A	128,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	14110	rrsB+	1542	139	95.0	rrsB+.l15.c17.ctg.5	139	64.3	0	.	n	.	0	C1038T	SNP	1038	1038	C	87	87	T	116	T	115	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	662	soxR	465	465	100.0	soxR.l15.c4.ctg.1	825	43.3	1	SNP	p	R20H	0	.	.	58	60	CGC	220	222	CGC	67;67;67	C;G;C	65;66;66	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	662	soxR	465	465	100.0	soxR.l15.c4.ctg.1	825	43.3	1	SNP	p	G121D	0	.	.	361	363	GGT	523	525	GGT	62;61;61	G;G;T	62;61;61	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	486	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	737	35.6	1	SNP	p	A12S	0	.	.	34	36	GCA	260	262	GCA	63;62;66	G;C;A	63;62;66	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	1602	tet-	1206	1206	99.92	tet-.l15.c30.ctg.1	1593	54.1	0	.	p	.	0	T171A	NONSYN	511	513	ACT	705	707	GCT	53;52;54	G;C;T	53;52;54	.	tetA;TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	648	tetC	594	594	99.66	tetC.l15.c30.ctg.1	1031	33.8	0	.	p	.	0	S152D	NONSYN	454	456	AGT	693	695	GAT	32;30;28	G;A;T	32;30;28	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetD.3000168.BX664015.204137_204554.417	tetD.3000168.BX664015.204137_204554.417	1	0	27	616	tetD	417	417	100.0	tetD.l15.c30.ctg.1	802	41.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tetD;TetD is a tetracycline efflux pump found exclusively in Gram-negative bacteria.
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	858	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1021	45.0	1	SNP	p	H64Y	0	.	.	190	192	CAC	382	384	CAC	70;69;69	C;A;C	70;69;69	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	858	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1021	45.0	1	SNP	p	N82H	0	.	.	244	246	AAT	436	438	AAT	52;52;55	A;A;T	52;52;55	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	856	tetR_1	624	624	100.0	tetR_1.l15.c4.ctg.1	1014	45.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	2054	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1915	56.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
